328 related articles for article (PubMed ID: 15728186)
1. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
Renfrow MB; Cooper HJ; Tomana M; Kulhavy R; Hiki Y; Toma K; Emmett MR; Mestecky J; Marshall AG; Novak J
J Biol Chem; 2005 May; 280(19):19136-45. PubMed ID: 15728186
[TBL] [Abstract][Full Text] [Related]
2. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
Takahashi K; Wall SB; Suzuki H; Smith AD; Hall S; Poulsen K; Kilian M; Mobley JA; Julian BA; Mestecky J; Novak J; Renfrow MB
Mol Cell Proteomics; 2010 Nov; 9(11):2545-57. PubMed ID: 20823119
[TBL] [Abstract][Full Text] [Related]
3. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
4. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy.
Renfrow MB; Mackay CL; Chalmers MJ; Julian BA; Mestecky J; Kilian M; Poulsen K; Emmett MR; Marshall AG; Novak J
Anal Bioanal Chem; 2007 Nov; 389(5):1397-407. PubMed ID: 17712550
[TBL] [Abstract][Full Text] [Related]
5. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring structural isomers in serum IgA1 o-glycosylation.
Takahashi K; Smith AD; Poulsen K; Kilian M; Julian BA; Mestecky J; Novak J; Renfrow MB
J Proteome Res; 2012 Feb; 11(2):692-702. PubMed ID: 22067045
[TBL] [Abstract][Full Text] [Related]
7. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
8. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
Ohyama Y; Yamaguchi H; Nakajima K; Mizuno T; Fukamachi Y; Yokoi Y; Tsuboi N; Inaguma D; Hasegawa M; Renfrow MB; Novak J; Yuzawa Y; Takahashi K
Sci Rep; 2020 Jan; 10(1):671. PubMed ID: 31959827
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of O-glycosylation in the hinge region of human IgA1.
Novak J; Tomana M; Kilian M; Coward L; Kulhavy R; Barnes S; Mestecky J
Mol Immunol; 2000 Dec; 37(17):1047-56. PubMed ID: 11399322
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
[TBL] [Abstract][Full Text] [Related]
12. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
14. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
Horie A; Hiki Y; Odani H; Yasuda Y; Takahashi M; Kato M; Iwase H; Kobayashi Y; Nakashima I; Maeda K
Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
[TBL] [Abstract][Full Text] [Related]
15. Structural features of IgA molecules which contribute to IgA nephropathy.
Feehally J; Allen AC
J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
[TBL] [Abstract][Full Text] [Related]
16.
Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
18. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
Mestecky J; Tomana M; Moldoveanu Z; Julian BA; Suzuki H; Matousovic K; Renfrow MB; Novak L; Wyatt RJ; Novak J
Kidney Blood Press Res; 2008; 31(1):29-37. PubMed ID: 18182777
[TBL] [Abstract][Full Text] [Related]
19. Separation of Two Distinct O-Glycoforms of Human IgA1 by Serial Lectin Chromatography Followed by Mass Spectrometry O-Glycan Analysis.
Lehoux S; Ju T
Methods Enzymol; 2017; 585():61-75. PubMed ID: 28109443
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
Novak J; Barratt J; Julian BA; Renfrow MB
Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
